They are working as peer mentors to veteran students. Some are studying medicine are practicing performing exams on patients. UC San Diego’s record-setting population of more than 40,000 students are working toward their degree this fall with a hybrid of in-person and remote instruction.
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer. Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
David Gonzalez’s “a-ha” moment came when a physician-colleague, George Sakoulas, MD, shared with him one of the biggest problems faced in clinical practice: How long it takes to diagnose a patient.
Jennifer Le thought of her many distant colleagues at the Hospital for Tropical Diseases in Vietnam when she read a news article about one of their patients—a 42-year-old Scottish pilot who had recovered from COVID-19 after two-and-a-half months in a medically induced coma.
UC San Diego researchers discovered that tumor cells in younger and female patients accumulate cancer-causing mutations that are more poorly presented to the immune system, better enabling tumors to escape detection and clearance.
UC San Diego launched the Dissemination and Implementation Science Center earlier this year to provide researchers and practitioners with the training, technical assistance, mentoring and resources they need to conduct research that is meaningful in real-world settings.
Residents in the School of Medicine this week launched RISE: Residents In Solidarity with Emerging Leaders. RISE is a 12-month "near-peer" mentorship program that pairs residents with rising third-year medical students who are underrepresented minorities in medicine.
By mapping molecular changes in the genome over time, UC San Diego researchers developed a formula to more accurately compare dog age to human age—a tool that could also help them evaluate how well anti-aging products work.
Natasha Martin’s heart stopped when she first saw a photo from Wuhan, China, depicting a huge hospital ward of patients on ventilators—all unable to breathe on their own due to an unusual pneumonia caused by a novel coronavirus.
With help from med-tech company BD, UC San Diego’s Microsetta Initiative pivots from crowdsourced microbiome studies to coronavirus data collection.